Stock Events

Stock Events

Search...

Marker Therapeutics (MRKR) Q2 2024 Earnings

15MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.47

-0.4

-0.32

-0.25

Details

Expected EPS

-0.25

Actual EPS

-0.27

Surprise EPS

-0.02

Surprise Percent

+8%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.27 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.